Call for Application to Researchers for Joint Research Project between Ono Pharmaceutical and BioMed X
- Research Theme: New Strategies to Engage Neurophils in Solid Tumors -
OSAKA, Japan, Jan. 9, 2024 /PRNewswire/ -- Ono Pharmaceutical Co., Ltd. (Osaka, Japan) informed that it has started a new collaboration with BioMed X (Heidelberg, Germany) on cancer immunotherapies and has been inviting researchers who are interested in this research project via BioMed X.
For details, please refer to the following BioMed X press release and application guidelines for the research project:
(Summary of applications) For more information, please refer to the above link. Research theme: New Strategies to Engage Neutrophils in Solid Tumors Project term: 3 - 5 years Deadline for applications: February 18, 2024
Renova Therapeutics, a biotechnology company developing gene therapy-based treatments for cardiovascular and metabolic diseases, announced today that it has focused its development and commercialization efforts for its RT-100 and RT-200 gene...
Organovo Holdings, Inc. ("Organovo" or the "Company"), a clinical stage biotechnology company focused on developing novel treatment approaches based on demonstration of clinical promise in three-dimensional (3D) human tissues, today announced the...
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology...
NCPDP announced today highlights from its 2024 Annual Technology & Business Conference, Innovation Starts Here. "NCPDP's standards and guidance are inherently innovative, and the work we continue to do will expand interoperability to support the...
Edwards Lifesciences today announced the European launch of the SAPIEN 3 Ultra RESILIA valve, the only transcatheter aortic heart valve to incorporate the company's breakthrough RESILIA tissue technology, designed to extend the valve's durability.*...
DaVinci Laboratories, a division of FoodScience, LLC of Williston, Vermont is recalling 72 bottles of Amyloid Complete because it may contain undeclared shellfish (Shrimp and Crab). People who have an allergy or severe sensitivity to shellfish run...